Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Accenture
Fuji
Argus Health
Cipla
Fish and Richardson

Generated: July 23, 2019

DrugPatentWatch Database Preview

Patent: 7,704,495

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,704,495
Title:Process for producing cartilage cells for transplantation
Abstract: This invention is intended to provide a method to quickly obtain a large amount of normal human chondrocytes or a mass thereof without fear of bacterial or viral infection. Namely, a method of producing human chondrocytes characterized by comprising co-culturing chondrocytes obtained from a cartilage having perichondrium, for example, auricular cartilage together with the perichondrium; and a method of producing human chondrocytes characterized by comprising monolayer or multilayer seeding the cultured cells once or more and culturing to give a chondrocyte mass.
Inventor(s): Yanaga; Hiroko (Kitakyusyu-shi, Fukuoka, 802-0044, JP)
Assignee: Yanaga; Hiroko (Fukuoka, JP) Yanaga; Katsu (Fukuoka, JP)
Application Number:10/552,000
Patent Claims:see list of patent claims

Details for Patent 7,704,495

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Advance Biofactures SANTYL collagenase VIAL 101995 001 1965-06-04 ➤ Sign Up Yanaga; Hiroko (Fukuoka, JP) Yanaga; Katsu (Fukuoka, JP) ➤ Sign Up RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Medtronic
Harvard Business School
Chubb
Colorcon
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.